Article Versions Notes

Guan B, Zhou N, Wu C-Y, Li S, Chen Y-A, Debnath S, Hofstad M, Ma S, Raj GV, He D, et al. Validation of SV2A-Targeted PET Imaging for Noninvasive Assessment of Neuroendocrine Differentiation in Prostate Cancer. International Journal of Molecular Sciences. 2021; 22(23):13085. https://doi.org/10.3390/ijms222313085

Guan, Bing, Ning Zhou, Cheng-Yang Wu, Songye Li, Yu-An Chen, Sashi Debnath, Mia Hofstad, Shihong Ma, Ganesh V. Raj, Dalin He, and et al. 2021. "Validation of SV2A-Targeted PET Imaging for Noninvasive Assessment of Neuroendocrine Differentiation in Prostate Cancer" International Journal of Molecular Sciences 22, no. 23: 13085. https://doi.org/10.3390/ijms222313085

Guan, B., Zhou, N., Wu, C. -Y., Li, S., Chen, Y. -A., Debnath, S., Hofstad, M., Ma, S., Raj, G. V., He, D., Hsieh, J. -T., Huang, Y., Hao, G., & Sun, X. (2021). Validation of SV2A-Targeted PET Imaging for Noninvasive Assessment of Neuroendocrine Differentiation in Prostate Cancer. International Journal of Molecular Sciences, 22(23), 13085. https://doi.org/10.3390/ijms222313085